Long-term safety follow-up of patients with advanced heart failure treated with transendocardial delivery of muscle-derived stem/progenitor cells with overexpression of connexin-43

26 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Basic Science - Cardiac Diseases Gene Therapy, Cell Therapy HFA Premium Access Heart Failure 2018